Joseph M. Tuscano
Department of Internal Medicine
University of California
Davis Medical Center
Sacramento 95817
USA
Name/email consistency: high
- Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts. Tuscano, J.M., O'Donnell, R.T., Miers, L.A., Kroger, L.A., Kukis, D.L., Lamborn, K.R., Tedder, T.F., DeNardo, G.L. Blood (2003)